Peripheral Arterial Disease (Calf Pain When You Walk)

Time your next walk. Note the exact distance the ache starts, then stop and time how long it takes to clear.

If it is the same distance every time and it clears within a few minutes of simply standing still, ask your doctor for an ankle blood pressure test this week. If you get foot pain in bed at night, or a sore that has not healed in two weeks, do not wait and do not start walking training. Call your doctor today.

Takes one walk. No equipment needed.

The Verdict

The people with the worst leg circulation are usually the ones who never complain about it.

Think of the artery feeding your calf as a garden hose that has narrowed. At rest the trickle is plenty, so everything looks and feels fine. Start walking and the muscle asks for a firehose, gets a trickle, and cramps. Stand still for two minutes, demand drops back to what the hose can deliver, and the pain vanishes. The narrowing never changed, only the demand did, which is why the pain is so predictable. It is also why walking training works: it does not widen the hose, it teaches the muscle to do more with the trickle and grows tiny new side channels around the blockage.

What this actually is: the arteries feeding your leg have narrowed, and the same narrowing is happening in the arteries to your heart and brain, which is the part that actually matters.
What most people get wrong: a normal ankle test does not clear you, because in people with diabetes it misses roughly 4 in 10, and in general screening it can miss most of it.
Start here: walk three times a week for twelve weeks, building to 45 minutes including your rest stops, and get your blood pressure, cholesterol and smoking dealt with.

Best for

Adults over about 50 with calf pain that starts at a repeatable walking distance and clears within minutes of standing still.

Skip if

You have foot pain at night, a sore over two weeks old, or blackened skin. Those need an urgent appointment, not an exercise plan. Under 40 with clean risk factors? Two other conditions look identical and need different tests.

Want the full evidence? Keep scrolling

What Works

Cinematic rendering of calf musculature under load

Structured walking programme STRONG

The first-line treatment, and it has not been beaten by a procedure. Supervised exercise gained +186.8 m maximum walking distance versus control (95% CrI 136.4 to 237.6) across 46 randomized trials and 4256 patients, and beat plain walking advice by roughly 210 m in Cochrane's 21-trial review.

Dose: 2 to 3 sessions per week · minimum 6 weeks · 12 weeks modal · build to 30 to 45 minutes total session time including rest stops.
Method: walk until the ache reaches a moderate level, stand still until it clears (usually 2 to 5 minutes), repeat.
Honest note: no trial randomised frequency, session length or programme duration. "Three times a week for twelve weeks" is the most common protocol across trials, not a tested optimum.

Cardiovascular risk management alongside STRONG

Not the therapist's prescription to write, but routing the patient to it is the therapist's job. The mortality signal attached to a low ankle index is the strongest single finding on this page.

Exercise Prescription

Exercise	Dose	Frequency	Guide
Interval walking	Build to 30 to 45 min total session time	3 days/week, 12 weeks	Walk to moderate discomfort, stand still until it clears, repeat
Heel raises	3 × 12 to 15	3 days/week	Calf effort is fine; stop at the deep cramping ache
Sit-to-stand	3 × 10	3 days/week	No hands. Legs worked, no sharp pain
Cycling or arm ergometer	20 to 30 min	2 to 3 days/week	Substitute when walking is not possible, not a first choice

Tier 2 and Tier 3 options

Structured home programme MODERATE

Where supervised care does not exist, a structured home programme with a logbook or step counter gained +89.4 m short term (95% CrI 20.9 to 157.7), and was non-inferior to supervised care at 12 months on the six-minute walk in the SUNFIT trial (-11.6 m, 95% CI -36.4 to 13.0). The structure is the active ingredient, not the supervision.

Intensity matched to the goal MODERATE

Light-to-moderate intensity gained more walking distance (+223 m, 95% CI 174 to 271) than vigorous (+153 m). Vigorous won on fitness instead (VO2peak +3.0 vs +1.1 mL/kg/min). Pick the lever that matches what the patient wants.

Resistance training as an addition MODERATE

Six-minute-walk claudication onset improved by +82.23 m (95% CI 40.91 to 123.54) across 15 trials and 826 patients, with higher intensity doing better (p=0.02). Additive, not a replacement: walking still beats resistance training alone for walking endurance.

Alternative modes when walking is impossible LOW CERTAINTY

Cycling, arm ergometry and combinations showed no clear difference from supervised walking (SMD -0.11, 95% CI -0.33 to 0.11), but Cochrane rated the certainty low. Substitute without guilt, default to walking.

Nordic walking EMERGING

No benefit over standard supervised walking (SMD -0.79, 95% CI -2.81 to 1.24) across 5 trials. A home-based subgroup favoured it, resting mainly on a single trial. The poles are not the active ingredient.

What Doesn't Work

Reassuring a symptomatic patient on a normal resting ankle index. The highest-cost error on this page, and it feels like good practice at the time.
Plain walking advice with no structure. It did not differ from a structured home programme on treadmill distance (SMD 0.30, 95% CI -0.45 to 1.05, P=0.43), and the structured arm is the one that beat nothing at all. Handing over an instruction is not handing over a programme.
Re-measuring the ankle index to prove the programme worked. It does not change with exercise therapy. A flat reading at 12 weeks says nothing about whether the treatment helped.
Spinal cord stimulation, pneumatic compression, prostanoids and hyperbaric oxygen for limb-threatening disease. The Global Vascular Guidelines state their effectiveness has not been established.

Red Flags

Cinematic anatomical rendering of lower limb arterial circulation

Refer urgently to a vascular specialist if ANY ONE of these is present.

These three define chronic limb-threatening ischaemia, and the Global Vascular Guidelines state that all suspected cases go urgently to a vascular specialist (Conte 2019, PMID 31159978).

Rest pain, characteristically in the forefoot at night, relieved by hanging the leg out of bed.
Gangrene.
A lower limb ulcer present for more than 2 weeks.

Any one of them turns an exercise conversation into a referral. Do not start a walking programme in a limb that meets these criteria.

Emergency department immediately: sudden pain, pallor, pulselessness, numbness, weakness, or a perishing cold limb. That is acute limb ischaemia, a different emergency, and nothing should delay it.

Also refer, less urgently: an ankle-brachial pressure index at or below 0.90 in someone with no cardiovascular risk management in place. A low index carries all-cause mortality RR 2.52 (95% CI 2.26 to 2.82) and cardiovascular mortality RR 2.94 (2.72 to 3.18) across 43 cohorts and 94,254 participants (Hajibandeh 2017, PMID 27411571). This is a cardiovascular diagnosis that happens to present in the leg.

Return to Training

This condition does not restrict resistance training. The limiting factor is aerobic walking capacity, not mechanical load tolerance, so the client keeps the gym programme and adds the walking.

Red flag screen clear: no rest pain, no ulcer over 2 weeks, no gangrene.
12 weeks completed at 3 sessions per week, evidenced by a logbook or step counter.
Claudication onset time improved by at least 73 seconds, the anchor-based minimum clinically important difference (Gardner 2018).
Six-minute walk distance improved, judged against the 50 m margin used as clinically meaningful in SUNFIT.
The patient can complete their own stated walking goal, named at assessment.
A maintenance plan for beyond week 12 exists and the patient has agreed to it.
Cardiovascular risk management is in place with the GP.

Conviction

MODERATE overall, and it splits hard by claim.

Structured exercise improves walking distance over 3 to 12 months HIGH
Ankle index at or below 0.90 as a rule-in test in a symptomatic patient MOD-HIGH
A normal ankle index excludes the disease LOW
Supervised care beats a structured home programme on patient-relevant measures LOW
Exercise alters the arterial disease itself LOW
A low ankle index as a cardiovascular risk marker HIGH

What would change my mind on the durability claim

A multicentre randomized trial of at least 400 adults with symptomatic disease, exercise versus usual care, with the six-minute walk and a patient-reported walking measure as co-primary endpoints, followed to 36 months, with adherence reported as a pre-specified outcome, showing a difference beyond the 73-second threshold sustained at 36 months.

Nothing smaller will move it, because the current failure is specifically at two years and specifically in the pooled analysis of the 46 trials that already exist.

What would change my mind on the rule-out claim

A prospective diagnostic accuracy study of resting and post-exercise ankle index in an unselected primary-care or therapy population presenting with exertional leg pain, with duplex ultrasound as the reference standard and at least 300 participants.

The existing evidence characterises the test in referred populations and in screening populations. The population a therapist actually sees sits between them, and no study of it appeared in any of the seven literature sweeps run for this card.

Go Deeper

Tired of guessing whether a symptom is worth taking seriously? The Verdict reads the actual trials so you do not have to. One evidence review a week, free.

Join The Verdict

The Full Picture — Anatomy, Diagnosis & Evidence

What's Actually Going On

Cinematic cross-section of a narrowed lower limb artery

Atherosclerotic narrowing in the vessels above and below the knee puts a ceiling on how much blood can reach the working leg. At rest, collateral vessels cope, so the leg looks normal, feels normal and examines normal. That is not reassurance. That is the disease behaving exactly as expected.

Walking raises demand past the ceiling, the muscle goes ischaemic, and pain arrives at a reproducible workload. Stop, demand falls, pain clears in minutes.

The part that changes what you measure: exercise therapy is the first-line treatment and it does not open the artery. The physiology runs through blood vessel lining function, inflammation, muscle composition and the growth of tiny new vessels, and the ankle-brachial index does not change with supervised exercise therapy (Rodrigues 2020, PMID 31782277). The test that makes the diagnosis is not the test that measures the treatment.

How to Identify It

Cinematic rendering of ankle and foot vasculature

The single most useful subjective question is not about the pain. It is about the relief. Vascular claudication clears with standing still. Neurogenic claudication from a narrowed spinal canal typically needs sitting or leaning forward.

Test	Population	Performance
Resting ABPI ≤ 0.90 Sn 75% \| Sp 86%	Patients referred for angiography	+LR 4.18, -LR 0.29 (Xu 2013)
Resting ABPI Sn 61% \| Sp 92%	Mixed populations, ≥50% stenosis	95% CI 55 to 69 and 89 to 95 (Herraiz-Adillo 2020)
Resting ABPI Sn 60% \| Sp 87%	People with diabetes	Calcified vessels read falsely normal (Chuter 2021)
Resting ABPI Sn 7-34% \| Sp 96-100%	Unselected screening population	Single study, n=306 (Guirguis-Blake 2018)
Toe-brachial index Sn 81% \| Sp 77%	Where ankle vessels are incompressible	82% vs the ankle index's 52% in the 7 studies running both (Herraiz-Adillo 2020)

Read that sensitivity column downwards. The ankle index is a rule-in test whose rule-out power collapses as the chance of disease falls, and the miss rate is worst in people with diabetes, whose limbs are most at risk. A normal resting reading in a symptomatic patient does not exclude the disease.

Both the 2024 ACC/AHA and 2024 ESC guidelines recommend post-exercise ankle index testing when the resting value is normal but suspicion persists. No pooled accuracy figure for that test was found in any of the seven literature sweeps run for this card, so treat the recommendation as guideline-level and the accuracy as unquantified.

The Debate

Supervised versus home-based exercise

Cochrane, Hageman 2018, 21 RCTs, N=1400

Supervised exercise beat home-based on maximum treadmill walking distance, SMD 0.37 (95% CI 0.12 to 0.62).

vs

SUNFIT RCT, Sandberg 2023, N=166

Home-based was non-inferior to supervised at 12 months on the six-minute walk, -11.6 m (95% CI -36.4 to 13.0) against a 50 m margin.

They do not disagree about treatment. They disagree about instrument. Supervised treadmill training preferentially improves treadmill walking; home programmes preferentially improve corridor walking. Offer supervised care where it exists, and do not treat a structured home programme as a second-rate substitute, because on the endpoint closest to real life it held its own for a year.

Walking into pain

Standing clinical convention

Claudication training must be performed into moderate-to-severe pain.

vs

Fassora 2022, N=1132

Protocols that never used pain as the target, guided by heart rate or perceived effort instead, gained +223 m and +153 m.

Walking into pain is not a precondition for benefit. That matters enormously for adherence. The evidence shows pain-free protocols work; it does not show they beat pain-threshold protocols head to head, and this page does not claim they do.

Procedure versus exercise

Common practice

Endovascular revascularisation is widely performed for claudication.

vs

Cochrane, Fakhry 2018

Against supervised exercise, no significant difference in walking distance (SMD -0.42, 95% CI -0.87 to 0.04).

Exercise is not the consolation prize, it is the comparator the procedure has not beaten for walking distance. The one place the combination clearly wins is reducing further procedures (OR 0.27, 95% CI 0.13 to 0.55), which is a different benefit from walking further.

Honest Limitations

The trials measure the endpoint the trial trains

The finding: supervised care beat home care on maximum treadmill distance.
The gap: supervised treadmill programmes preferentially improve treadmill performance and home programmes preferentially improve corridor walking. A pooled result favouring supervision is partly an artefact of which test was chosen, and neither test is "can I get to the shops".
The adjustment: judge the programme on the six-minute walk and the patient's own goal, against Gardner's anchor-based 73-second threshold.

Trial adherence is not real-world adherence, and the gap is fourfold

The finding: adherence to supervised exercise in the Cochrane trials was around 80%.
The gap: SUNFIT, a multicentre trial running in ordinary services, reported 24% and 26% fully adherent in its home and supervised arms.
The adjustment: read every number on this page against a one-quarter adherence denominator, and treat structure and scheduled contact as part of the prescription rather than as admin.

Nothing here has been shown to last

The finding: supervised exercise gained 186.8 m short term and 201.1 m at one to two years, across 46 trials and 4256 patients.
The gap: at two years or more, no treatment tested beat control. Not exercise, not home exercise, not the procedure, not the combination, not cilostazol.
The adjustment: this argues for maintenance and review, not against treatment. Do not discharge at twelve weeks assuming the gain holds. Build the follow-on in at the start.

The Nuance

Cinematic comparison rendering of lower leg compartments and vasculature

Three conditions share one symptom script, and this is the part clinical teaching gets wrong. Vascular claudication, chronic exertional compartment syndrome and popliteal artery entrapment all produce pain at a reproducible distance that clears within minutes of stopping. The words the patient uses cannot separate them. Age band, vascular risk profile and the ankle index can. Peripheral arterial disease belongs to the older smoker, diabetic or hypertensive patient. Entrapment belongs to the young, heavily trained one. Compartment syndrome sits with the young athlete and a normal ankle reading.

The inversion that actually matters. The intuitive triage is that the patient with textbook claudication is the one to worry about. The data say the opposite. McDermott and colleagues followed 415 people with peripheral arterial disease for up to seven years. Compared with people who had classic claudication, those who were always symptom-free lost mobility roughly three times faster (HR 2.94, 95% CI 1.39 to 6.19, P=.005), and so did those with leg pain both on exertion and at rest (HR 2.89, 1.47 to 5.68, P=.002), after adjusting for age, sex, other conditions and the ankle index itself. People who could walk through the pain and carry on were less likely to lose the six-minute walk (P=.047).

A clean, reproducible, stop-start calf pain is the better-prognosis version of this disease. The patient who reports nothing in particular, or who has quietly stopped walking far enough to trigger anything, is on the steeper decline. Asymptomatic disease carries the same excess cardiovascular mortality as symptomatic disease (Hooi 1999). A pathway that only reacts to complaints selects the better-prognosis patients into care and leaves the worse ones outside it.

Sources

McDermott MM, Ferrucci L, Liu K, et al. (2010). Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc. PMID 20550604. 415 people followed up to 7 years; always-asymptomatic HR 2.94 (95% CI 1.39 to 6.19).
Hageman D, Fokkenrood HJ, Gommans LN, et al. (2018). Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev. PMID 29627967. 21 RCTs, N=1400.
Thanigaimani S, Phie J, Sharma C, et al. (2021). Network meta-analysis comparing the outcomes of treatments for intermittent claudication. J Am Heart Assoc. PMID 33890475. 46 RCTs, N=4256; no treatment beat control at ≥2 years.
Fakhry F, Fokkenrood HJ, Spronk S, et al. (2018). Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Database Syst Rev. PMID 29518253. 10 RCTs, N=1087.
Fassora M, Calanca L, Jaques C, et al. (2022). Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic PAD. Vasc Med. PMID 34579581. N=1132.
Xu D, Zou L, Xing Y, et al. (2013). Diagnostic value of ankle-brachial index in peripheral arterial disease. Can J Cardiol. PMID 22926041. 4 studies, 569 patients, 922 limbs.
Herraiz-Adillo Á, Cavero-Redondo I, Álvarez-Bueno C, et al. (2020). The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb PAD. Atherosclerosis. PMID 33036766. 35 ABI studies, 1318 patients.
Chuter VH, Searle A, Barwick A, et al. (2021). Estimating the diagnostic accuracy of the ankle-brachial pressure index for detecting PAD in people with diabetes. Diabet Med. PMID 32740980. 33 studies.
Guirguis-Blake JM, Evans CV, Redmond N, et al. (2018). Screening for peripheral artery disease using the ankle-brachial index: evidence report for the USPSTF. JAMA. PMID 29998343. N=5864.
Hajibandeh S, Hajibandeh S, Shah S, et al. (2017). Prognostic significance of ankle brachial pressure index. Vascular. PMID 27411571. 43 cohorts, 94,254 participants.
Conte MS, Bradbury AW, Kolh P, et al. (2019). Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. PMID 31159978. Practice guideline; source for every referral statement here.
Sandberg A, Bäck M, Cider Å, et al. (2023). SUNFIT randomized clinical trial. Eur J Cardiovasc Nurs. PMID 35917174. N=166; home-based non-inferior at 12 months.
Gardner AW, Montgomery PS, Wang M (2018). Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes in PAD. Vasc Med. PMID 29671381. N=180.
Parmenter BJ, Mavros Y, Ritti Dias R, et al. (2020). Resistance training as a treatment for older persons with peripheral artery disease. Br J Sports Med. PMID 30979698. 15 trials, N=826.
Rodrigues E, Silva I (2020). Supervised exercise therapy in intermittent claudication: clinical impact and limitations. Int Angiol. PMID 31782277. Source for the ankle index not changing with exercise.
Hooi JD, Stoffers HE, Knottnerus JA, et al. (1999). The prognosis of non-critical limb ischaemia. Br J Gen Pract. PMID 10622019. 16 population-based studies.

Educational self-management guidance, not personalized medical treatment. If you have any of the red flags above, contact a clinician rather than acting on this page.